Page 16 - 南京医科大学自然版
P. 16

第44卷第10期
               ·1332 ·                           南 京    医 科 大 学 学         报                        2024年10月


              A                                   B                         C
                    IP:  IgG  S100A4                     IP:  IgG  HA               IP: IgG  S100A4
                 IB 25 kDa—            SUMO1⁃S100A4  IB 15 kDa—     Flag⁃UBC9  IB 25 kDa—           SUMO1⁃S100A4
                  10 kDa—              S100A4         10 kDa—       HA⁃S100A4    10 kDa—            S100A4
                              Input                           Input                          Input
                  10 kDa—              S100A4         15 kDa—       Flag⁃UBC9    10 kDa—            S100A4
                  15 kDa—              UBC9           10 kDa—       HA⁃S100A4    15 kDa—            Flag⁃UBC9
                  70 kDa—              SENP1          40 kDa—       β⁃actin      70 kDa—            Flag⁃SENP1
                  70 kDa—              SENP2        Flag⁃UBC9: +  +              40 kDa—            β⁃actin
                                                    pcDNA3.1: +   -
                  70 kDa—              SENP3       HA⁃S100A4: -   +            pcDNA3.1: +  +  -  -
                                                                               Flag⁃UBC9: -  -  +  -
                  40 kDa—              β⁃actin           IP:  IgG  HA         Flag⁃SENP1: -  -  -  +
                    shScr:+ + - - - -
                  shUBC9:- - + - - -                 IB 70 kDa—     Flag⁃SENP1
                  shSENP1:- - - + - -                 10 kDa—       HA⁃S100A4
                  shSENP2:- - - - + -
                  shSENP3:- - - - - +                         Input
                                                      70 kDa—       Flag⁃SENP1
                                                      10 kDa—       HA⁃S100A4
                                                      40 kDa—       β⁃actin
                                                   Flag⁃SENP1:  +  +
                                                    pcDNA3.1:  +  -
                                                   HA⁃S100A4:  -  +
                 A:In MIA PaCa⁃2 cells with knockdown of UBC9,SENP1,SENP2 or SENP3 by shRNA,protein A/G magnetic beads were conjugated with anti⁃
              S100A4 antibody and precipitated with cell lysates,and the degree of SUMOylation was detected by anti⁃SUMO1 antibody. B:The interaction between
              S100A4 and UBC9 or SENP1 was detected by co⁃immunoprecipitation. C:S100A4 SUMOylation was detected with an anti⁃SUMO1 antibody in MIA
              PaCa⁃2 cells transfected with Flag⁃UBC9 or Flag⁃SENP1.
                  图5 SUMO化相关酶UBC9和SENP1参与MIA PaCa⁃2细胞中S100A4 蛋白的SUMO化与去SUMO化修饰过程
               Figure 5 UBC9 and SENP1 are involved in the SUMOylation and deSUMOylation of S100A4 protein in MIA PaCa⁃2 cells


                        A                                       B
                                       Nucleus                                  Nucleus
                           10 kDa—               S100A4          10 kDa—                      S100A4
                           40 kDa—               β⁃actin         40 kDa—                      β⁃actin

                           70 kDa—               Lamin B1        70 kDa—                      Lamin B1
                                      Cytoplasm                                Cytoplasm
                           10 kDa—               S100A4          10 kDa—                      S100A4
                           40 kDa—               β⁃actin         40 kDa—                      β⁃actin
                           70 kDa—               Lamin B1        70 kDa—                      Lamin B1
                                  shScr  shUBC9 shSENP1                  WT   K22R  K96R  DKR


                 A:Results of protein immunoblotting using cytoplasmic and nuclear extracts. The expression of endogenous S100A4 in the nucleus and cytoplasm
              of shUBC9,shSENP1 and negative control MIA PaCa⁃2 cells was detected. B:Expression of S100A4 in the nucleus and cytoplasm of cells transfected
              with different mutant forms of S100A4.
                                      图6   S100A4在不同处理的胰腺癌细胞中胞核与胞质表达情况
                   Figure 6  Expression of S100A4 in the nucleus and cytoplasm of pancreatic cancer cells with different treatment

              细胞迁移侵袭的能力。                                        蛋白质参与      [19] 。1989 年,Ebralidze [20] 、Ishikawa [21] 等
                                                                鉴定出S100A4,并首次证明其与肿瘤转移相关。最
              3  讨 论
                                                                早在人乳腺癌中发现 S100A4 的过表达可作为预后
                  肿瘤转移是影响预后的关键因素,也是导致治                          不良和高转移潜力的指标             [22] 。对于食管鳞状细胞
              疗失败和患者死亡的首要原因。癌症转移是一个                             癌、胃癌、结直肠癌、肝细胞癌、PC 和胆囊癌                  [23-24] 等
              多步骤的过程,在分子水平上有许多与转移相关的                            消化系统肿瘤,S100A4是其不良预后和手术切除或
   11   12   13   14   15   16   17   18   19   20   21